Daniel Decker, MD
Urology · Mountain Home, ARNPI 1205039807
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,544 of the $6,168 with a category attached, or 89.9%. It is spread thinly across 39 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in AR, where the typical reported total is $5,249.
Across 285 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Medtronic$865
- Astellas Pharma US Inc$676
- Johnson & Johnson$527
- Boston Scientific$390
- Pfizer$379
- plus $2K from 33 others
What the payments were for
- Speaking & faculty fees$4738%
- Food & beverage$5,54490%
- Education$1512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 42 | $1,225 |
| Medtronic(2 entities) | 27 | $865 |
| Astellas Pharma US Inc | 40 | $676 |
| Johnson & Johnson | 30 | $527 |
| Boston Scientific | 17 | $390 |
| Pfizer | 20 | $379 |
| Myriad Genetic Laboratories, Inc. | 13 | $268 |
| Coloplast | 14 | $249 |
| Laborie Medical Technologies Corp. | 3 | $136 |
| Tolmar, Inc. | 6 | $127 |
| AbbVie(2 entities) | 6 | $105 |
| Urogen Pharma, Inc. | 5 | $103 |
| Bayer | 5 | $98 |
| Baudax Bio Inc. | 5 | $95 |
| Procept Biorobotics Corporation | 4 | $84 |
| Blue Earth Diagnostics | 5 | $77 |
| Tolmar Pharmaceuticals, Inc. | 3 | $66 |
| Olympus America Inc. | 4 | $64 |
| Teleflex LLC | 3 | $58 |
| Myovant Sciences Inc. | 4 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $50 |
| Accord Healthcare, Inc. | 2 | $49 |
| Dendreon Pharmaceuticals LLC | 3 | $46 |
| Endo Pharmaceuticals Inc. | 3 | $41 |
| 180 Medical, Inc. | 2 | $38 |
| Merck | 2 | $33 |
| Cook Medical LLC | 2 | $28 |
| AstraZeneca | 1 | $20 |
| Tosoh Bioscience, Inc. | 1 | $19 |
| ABC Home Medical Supply, Inc. | 1 | $18 |
| Neotract Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Philips North America LLC | 1 | $16 |
| Amgen | 1 | $15 |
| Caris MPI, Inc. | 1 | $15 |
| Angiodynamics, Inc. | 1 | $14 |
| Convatec Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics r-SNM System$473
- INTERSTIM$115
How this compares
$6,168 in reported general payments places this provider in the 50th percentile of 88 urology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 63 | $47,831 |
| MyrbetriqMirabegron | 77 | $46,866 |
| Abiraterone Acetate | 18 | $34,832 |
| Finasteride | 661 | $7,383 |
| Tamsulosin Hcl | 580 | $6,180 |
| Solifenacin Succinate | 114 | $3,194 |
| Oxybutynin Chloride ErOxybutynin Chloride | 124 | $2,553 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 99 | $1,922 |
| Testosterone Cypionate | 36 | $1,254 |
| Ciprofloxacin Hcl | 292 | $927 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 487 | $896 |
| Bicalutamide | 27 | $602 |
| Oxybutynin Chloride | 34 | $592 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 123 | $522 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 31 | $430 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $51 | $47,83163 claims |
| Astellas Pharma US IncMyrbetriq | $676 | $46,86677 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 88 urology providers in Arkansas.
Other urology in Mountain Home
- Austin BarberMountain Home$7K
- Jason LindsayMountain Home$4K
- Donald MooneyLittle Rock$148K
- Timothy GoodsonLittle Rock$147K
- Ronald KuhnNorth Little Rock$138K
- Caleb BozemanLittle Rock$136K
- David CoussensLittle Rock$134K
- Timothy LangfordLittle Rock$133K
- Kevin ClaybrookLittle Rock$132K
- Gail JonesLittle Rock$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.